Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MBS ETF
MBB
|
+$1.13B |
| 2 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$821M |
| 3 |
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
|
+$770M |
| 4 |
ExxonMobil
XOM
|
+$605M |
| 5 |
Johnson & Johnson
JNJ
|
+$599M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LPT
Liberty Property Trust
LPT
|
+$139M |
| 2 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$75.9M |
| 3 |
ZAYO
Zayo Group Holdings, Inc.
ZAYO
|
+$48.7M |
| 4 |
Darden Restaurants
DRI
|
+$41.9M |
| 5 |
MDCO
Medicines Co
MDCO
|
+$39M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.64% |
| 2 | Healthcare | 13.41% |
| 3 | Financials | 11.59% |
| 4 | Industrials | 9.19% |
| 5 | Consumer Discretionary | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1776
Akebia Therapeutics
AKBA
$351M
| $5.63M | ﹤0.01% |
742,612
+13,991
| +2% | +$109K |
|
1777
Argan
AGX
$8.31B
| $5.59M | ﹤0.01% |
161,739
+13,594
| +9% | +$564K |
|
|
SP
1778
DELISTED
SP Plus Corporation
SP
| $5.58M | ﹤0.01% |
268,754
+14,414
| +6% | +$527K |
|
|
UN
1779
DELISTED
Unilever NV New York Registry Shares
UN
| $5.57M | ﹤0.01% |
114,071
-4,142
| -4% | -$227K |
|
|
GES
1780
DELISTED
Guess Inc
GES
| $5.56M | ﹤0.01% |
821,401
+56,894
| +7% | +$991K |
|
1781
Tenable Holdings
TENB
$3.96B
| $5.56M | ﹤0.01% |
254,310
+4,489
| +2% | +$111K |
|
1782
Addus HomeCare
ADUS
$2.18B
| $5.54M | ﹤0.01% |
81,924
+1,124
| +1% | +$97.2K |
|
1783
Enanta Pharmaceuticals
ENTA
$377M
| $5.53M | ﹤0.01% |
107,540
-1,479
| -1% | -$78.8K |
|
|
CADE
1784
DELISTED
Cadence Bancorporation
CADE
| $5.5M | ﹤0.01% |
840,060
+58,263
| +7% | +$804K |
|
1785
Alector
ALEC
$168M
| $5.5M | ﹤0.01% |
227,910
+45,536
| +25% | +$1.16M |
|
1786
Archrock
AROC
$6.26B
| $5.5M | ﹤0.01% |
1,461,561
-44,255
| -3% | -$320K |
|
1787
Douglas Dynamics
PLOW
$972M
| $5.49M | ﹤0.01% |
154,558
+16,158
| +12% | +$757K |
|
|
MRC
1788
DELISTED
MRC Global
MRC
| $5.48M | ﹤0.01% |
1,285,904
+170,112
| +15% | +$1.6M |
|
|
LNW
1789
DELISTED
Light & Wonder
LNW
| $5.47M | ﹤0.01% |
563,971
+52,902
| +10% | +$1.08M |
|
1790
Enviri
NVRI
$651M
| $5.46M | ﹤0.01% |
783,095
+78,136
| +11% | +$1.07M |
|
|
WBT
1791
DELISTED
Welbilt, Inc.
WBT
| $5.45M | ﹤0.01% |
1,062,121
+58,023
| +6% | +$698K |
|
1792
Interface
TILE
$2.03B
| $5.45M | ﹤0.01% |
720,382
+50,858
| +8% | +$710K |
|
1793
US Physical Therapy
USPH
$1.18B
| $5.44M | ﹤0.01% |
78,865
+1,326
| +2% | +$140K |
|
1794
MACOM Technology Solutions
MTSI
$20.9B
| $5.44M | ﹤0.01% |
287,257
+5,248
| +2% | +$133K |
|
1795
TG Therapeutics
TGTX
$7.07B
| $5.43M | ﹤0.01% |
551,936
+38,888
| +8% | +$491K |
|
|
SASR
1796
DELISTED
Sandy Spring Bancorp Inc
SASR
| $5.43M | ﹤0.01% |
239,831
+20,259
| +9% | +$645K |
|
|
INFN
1797
DELISTED
Infinera Corporation Common Stock
INFN
| $5.43M | ﹤0.01% |
1,023,846
+26,267
| +3% | +$180K |
|
1798
Inspire Medical Systems
INSP
$1.5B
| $5.4M | ﹤0.01% |
89,635
+1,915
| +2% | +$142K |
|
1799
Twist Bioscience
TWST
$6.19B
| $5.4M | ﹤0.01% |
176,440
+34,908
| +25% | +$938K |
|
1800
First Busey Corp
BUSE
$2.6B
| $5.39M | ﹤0.01% |
315,044
+4,077
| +1% | +$94.2K |
|
Similar funds
Charles Schwab's Q1 2020 Portfolio in Review
As of Q1 2020, Charles Schwab held 3,284 positions worth $170B, down 8.5% from $186B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab deployed $31.1B of net new capital in Q1 2020, opening 103 new positions and adding to 2,418 existing holdings. Its largest new stake was iShares MBS ETF: 10,382,066 shares worth $1.15B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Darden Restaurants, an estimated $41.9M trimmed.
- Charles Schwab's largest Q1 2020 buy was iShares MBS ETF: 10,382,066 shares worth $1.15B.
- Charles Schwab added most to ExxonMobil in Q1 2020, an estimated $605M increase.
- Charles Schwab's biggest Q1 2020 reduction was Darden Restaurants, cutting an estimated $41.9M.
- Charles Schwab fully exited Liberty Property Trust in Q1 2020, selling an estimated $139M.
- Charles Schwab's ten largest holdings make up 17% of its $170B portfolio in Q1 2020.
- Charles Schwab opened 103 new positions and closed 50 in Q1 2020.
- Charles Schwab's portfolio value fell 8.5% quarter-over-quarter to $170B.
Based on Charles Schwab's 13F filing for Q1 2020, filed 15 May 2020.